Editas Medicine to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that management will participate in the following upcoming investor conferences:

• 2022 Wells Fargo Healthcare Conference Format: Fireside ChatDate: Wednesday, September 7, 2022Time: 1:55 p.m. ETLocation: Everett, MA

• Morgan Stanley 20th Annual Global Healthcare Conference Format: Fireside ChatDate: Monday, September 12, 2022Time: 10:30 a.m. ETLocation: New York, NY

• Baird 2022 Global Healthcare Conference Date: Tuesday, September 13, 2022Location: New York, NY

The fireside chats will be webcast live and can be accessed through the “Investors” section of the Company’s website at www.editasmedicine.com. An archived replay will be available for approximately 30 days following each event.

About Editas MedicineAs a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. Editas Medicine is the exclusive licensee of Harvard and Broad Institute’s Cas9 patent estates and Broad Institute’s Cas12a patent estate for human medicines. For the latest information and scientific presentations, please visit www.editasmedicine.com.

Media Contact:Cristi Barnett(617) 401-0113[email protected]

Investor Contact:Ron Moldaver(617) 401-9052[email protected]

You May Also Be Interested In

• Corner Table Restaurants Brings Together The Smith and Parla in 17,000-Square-Feet on West 41st Street, Anchoring 42BELOW’s Burgeoning Food Scene
• AnswersMD Welcomes Board-Certified Family and Sports Medicine Physician Divino D'Alessio Jr., MD, CAQSM to Its New Boca Raton Office
• 41caijing Connects Global Brands with Media at IFA 2026, Helping More Journalists Discover Their Stories